PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • s, monoclonal antibodies, and medical devices.Paul's litigation experience is complemented by his experience with the preparation and prosecution of patent and trademark applications, as well as his continued involvement as an instructor and conference organizer in connection with matters related to intellectual property litigation and trial tactics.Prior to joining the firm, Paul was a partner in
http://www.w3.org/ns/prov#wasQuotedFrom
  • wsgr.com